Venture-capital firms are backing companies working to tackle the problem of ‘undruggable’ proteins, potentially enabling new treatments for cancer and other diseases.
As crypto reels, a new fund nabs five times the amount of its predecessor. ‘Now’s the time to be doubling down, amidst the market carnage,’ a Volt co-founder says.
The rocket company led by Elon Musk has raised at least $1.5 billion in its latest funding round, as it pushes ahead with ambitious projects.
The firm wrapped up its predecessor flagship fund with $12.5 billion last June.
NEWSLETTERS
data & interactives
WSJ Pro looks into which body systems benefit most from venture investments.